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Abstract 
Among endogenous adaptive systems to hypoxia, neuroglobin has been suggested as a novel 
oxygen-dependent neuroprotectant. However, neuroglobin´s protective role in postnatal 
susceptibility to hypoxic brain injury, as well as the mechanism underlying hypoxic regulation 
of neuroglobin, remains to be elucidated.    
We aimed to characterize i) maturational age-related regulation of neuroglobin in developing 
mouse brain in normoxic and hypoxic conditions, and ii) the role of hypoxia-inducible 
transcription factors (HIFs) as possible mediators of O2-dependent regulation of neuroglobin.  
In normoxia we showed that neuroglobin expression is regulated postnatally with increasing 
neuroglobin mRNA levels observed during brain maturation (P0-P14). By 
immunohistochemical analysis, we observed that neuroglobin is localized mainly in the 
cytoplasm of neurons. Exposure to acute (8% O2, 6h) and chronic systemic hypoxia (10% O2, 
7d) revealed that the neuroglobin response to hypoxia varies with maturational stage (P0 vs. 
P7) as well as with the severity of hypoxia, indicating a role for neuroglobin in neuronal 
acclimatisation to acute hypoxia during early stages of mouse brain maturation (P0). We also 
investigated neuroglobin regulation in primary mouse cortical neurons (DIV6) exposed to 
hypoxia (1% O2) in the presence or absence of the novel HIF prolyl hydroxylase inhibitor, 
FG-4497. The data generated strongly supports the notion that hypoxia-induced neuroglobin 
up-regulation is HIF-dependent.   
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Introduction 
Hypoxic and ischemic complications during the pre- and perinatal period are common causes 
of acquired neonatal brain damage (Rutherford et al., 2006). Clinical situations representing 
risk factors for perinatal brain injury include maternal hypotension or anemia, placental or 
umbilical cord complications (Low, 2004), as well as chronically compromised prenatal fetal 
oxygen supply due to placental abnormalities or maternal diseases (Terzidou and Bennett, 
2001). The complex neurotoxic cascade following cerebral hypoxic injury develops over a 
specific period of time when immediate early genes, inflammatory and excitotoxic pathways 
and, finally, apoptotic neurodegeneration are activated in vulnerable CNS regions such as 
cerebral cortex, hippocampus (CA1, CA3) and striatum (Northington et al., 2001).    
Among endogenous cerebral adaptive systems to hypoxia and ischemia, neuroglobin (Ngb), a 
recently discovered heme protein expressed in neurons of the central and peripheral nervous 
system and retina was suggested as a new neuroprotectant which is regulated by oxygen 
levels. In vitro, hypoxia has been shown to up-regulate Ngb transcript and protein expression 
in mouse cortical neurons (Sun et al., 2001), human glioblastoma (Emara et al., 2009) and 
neuronal cell lines (Schmidt-Kastner et al., 2006, Shao et al., 2009)). Moreover, increased 
Ngb expression in hypoxic adult rat brains (Li et al., 2006, Shao et al., 2009) as well as in 
focal cerebral ischemia (Sun et al., 2001) has been demonstrated. However, the in vivo 
observations are contradictory (Hundahl et al., 2005, Li et al., 2006, Schmidt-Kastner et al., 
2006) with findings varying depending on the experimental model used. Notably, studies on 
Ngb expression and regulation in developing brain, as well as its role in early response to 
cerebral hypoxia, are not available. 
Mechanisms underlying hypoxic induction of Ngb are still unclear. From in vitro 
experiments, involvement of hypoxia-inducible transcription factors (HIFs) (Sun et al., 2001) 
and hemin via the soluble guanylate cyclase/protein kinase G pathway (Zhu et al., 2002) have 
been proposed. Expression of Ngb was shown to be significantly induced in mouse cortical 
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neurons by CoCl2 and deferoxamine (DFO) (Sun et al., 2001). This compounds can stabilize 
the O2-regulated α-subunits of HIF which then heterodimerize with the constitutively 
expressed β-subunit to form an active HIF complex (Fandrey et al., 2006). Under normoxic 
conditions, HIF-α subunits are degraded rapidly by the ubiquitin-proteasome pathway, a 
process that is mediated via hydroxylation of specific prolyl residues by an enzyme family of 
HIF prolyl hydroxylases (prolyl hydroxylation domain protein [PHD]) that utilize di-oxygen 
and 2-oxoglutarate as co-substrates. Reduced activity of the PHDs, e.g. at low oxygen levels 
or by iron chelation, results in stabilisation of the HIF-α protein, heterodimerization (α/β), 
and nuclear translocation followed by binding to hypoxia response elements in promoters of 
specific responsive genes. HIFs up-regulate transcription of a cascade of hypoxia-inducible 
genes including erythropoietin, pro-apoptotic mediators (e.g. BNIP3), and vasoactive factors 
such as vascular endothelial growth factor (VEGF) and adrenomedullin (ADM), all of which 
can modify immediate cerebral response to hypoxia and ischemia in the adult (Stroka et al., 
2001) as well as developing brain (Bernaudin et al., 2002, Trollmann et al., 2008b). Based on 
these observations, involvement of HIF-1 in the hypoxic induction of cerebral Ngb expression 
has been hypothesized (Sun et al., 2001).  
To analyze HIF stabilization using a pharmacological agent that is more specific than CoCl2 
and DFO, we have used a novel prolyl-4-hydroxylase inhibitor, FG-4497 (Schneider et al., 
2009). FG-4497 inhibits the HIF-PHDs, stabilizes HIF-α subunits, and thus enhances 
formation of a functional HIF complex.  
Functionally, Ngb has been shown to protect neurons from hypoxic injury in vitro (Liu et al., 
2009) and in vivo in adult wild-type mice (Shao et al., 2009) and in Ngb-overexpressing 
transgenic mice (Sun et al., 2003). The protective properties of Ngb may be due to its ability 
to act as scavenger of reactive oxygen and nitrogen species (Brunori et al., 2005, Fordel et al., 
2007) and to maintain mitochondrial function (Liu et al., 2009, Yu et al., 2009). Furthermore, 
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anti-apoptotic effects of Ngb via reduction of cytochrom c have been reported (Fago et al., 
2006, Raychaudhuri et al., 2009). The role of Ngb in age-related susceptibility to 
hypoxic/ischemic brain injury remains to be established.   
The aim of the present study was to characterize maturational postnatal expression of Ngb in 
developing mouse brain during normoxia and systemic hypoxia using a mouse model of acute 
and chronic perinatal hypoxia (Trollmann et al., 2008a). In addition, in vitro and in vivo 
experiments were performed to understand the role of HIF in hypoxia-induced induction of 
Ngb.  
 
Methods  
Animal experiments. Neonatal C57BL/6 wild-type mice (Charles River Laboratories, 
Germany) were exposed to acute and chronic systemic hypoxia using a closed hypoxia 
chamber (Hypoxic Workstation INVIVO2 1000, Biotrace International, UK). For this 
purpose, neonatal mice were kept at continuous systemic hypoxia with FiO2 of 8% for 6 h 
(acute hypoxia group) at postnatal day 0 (P0, n=30) and P7 (n=30). To analyze effects of 
chronic systemic hypoxia, 7-day-old mice (P7) were kept under continuous systemic hypoxia 
with FiO2 of 10% for 7 d (n=30). To enable adjustment to the hypoxic environment, O2 
deprivation was done gradually by decreasing the FiO2 in 2 % O2 steps every 10 min. 
Controls (neonatal mice, n=30 per group) were kept in the INVIVO2 chamber under room air. 
For reoxygenation experiments, neonatal mice were kept in the chamber at room air (21% O2) 
for 24 h, 72 h or 7 d together with their dams (to allow for normal temperature and nutrition). 
Animal experiments were performed according to protocols approved by local government 
(Regierung Mittelfranken, Germany) according to national and European law. 
After the incubation period, neonatal brains were immediately dissected (without 
reoxygenation of the hypoxic groups), frozen in liquid nitrogen and stored at -80 °C until 
protein (n=3 per group) and mRNA extraction (n=5 per group) was performed. For 
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immunohistochemical studies, brains (n=3 per group) were embedded in 4% 
paraformaldehyde. Coronal sections at the level of the dorsal hippocampus were examined to 
analyze parietal cortex and hippocampus known to show selective vulnerability to hypoxia at 
early development. Mouse brain maturation at P0 and P7 approximately corresponds to that of 
the human brain at mid-gestation and near-term, respectively (Dobbing and Sands, 1979). 
Pharmacological HIF stabilization. Neonatal C57BL/6 wild-type mice were treated with the 
HIF prolyl hydroxylase inhibitor (PHI) FG-4497 (FibroGen; San Francisco; USA) under 
normoxic conditions at P0 (n=15) or P7 (n=15). FG-4497 (patent-registered 
US20040254215A1) was dissolved according to the instructions of the manufacturer (100 mg 
FG-4497 to 9.675 ml of 5% Dextrose to 325 µl of 1 N NaOH), and was injected i.p. (injection 
volume 0.1 ml) in a single dose of 30 (n=5), 60 (n=5) and 100 mg/kg (n=5). Age-matched 
controls were treated with NaCl 0.9% i.p. (n=10) or remained non-treated (n=10). After the 
treatment period of 6 h, PHI-treated brains and controls were dissected, frozen in liquid 
nitrogen and stored at -80°C until mRNA extraction. A 6-hour treatment interval was decided 
according to observations on protective effects of other PHI than FG-4497 in vivo in adult rats 
(Siddiq et al., 2005, Bernhardt et al., 2006). Specificity of FG-4497 has been shown in adult 
and neonatal mouse brain (Schneider et al., 2009).  
Primary cortical neuronal cultures. The dorsal telencephalon was dissected from E14 
C57BL/6 wild-type mice (Charles River Laboratories, Germany) following a published 
protocol (Sestan et al., 1999). Briefly, cortices of E14 mouse pups were dissected aseptically 
in cold 1x HBSS (+) solution with MgCl2 and CaCl2 following decapitation. The meninges 
were removed, cortices were collected in 1x HBSS (+) and after washing in 1x HBSS (-) 
without MgCl2 and CaCl2 but with Pyruvate were treated with trypsin DNAse. After washing 
in DMEM solution with Pyruvate and fetal calf serum, tissues were dissociated by triturating 
in serum free media to make a single cell suspension. The serum free medium 
(DMEM+Glutamax) was supplemented with B-27 supplement, Albumax, Sodium Pyruvate 
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and penicillin–streptomycin. Arabinoside (2×10−5 M) was used for the inhibition of astrocyte 
multiplication. Cells were plated at a density of 5×103 cells/cm2 onto plastic Petri dishes 
coated with poly-L-lysine in borate buffer, and were incubated with the serum free media for 
6 d (DIV6) in normal atmosphere with 5% CO2. At DIV6, cultures were incubated with FG-
4497 (5, 30, 60, 200 µM) for 6 h in normoxic (21% O2) or hypoxic (1% O2, 5% CO2, 94% N2) 
conditions. Cell viability was assessed by lactate dehydrogenase measurement. Experiments 
were performed at least three times. Cells were lysed and probed for HIF-1α by western blot 
analysis as previously described (Trollmann et al., 2008b). Blots were quantified 
desitometrically using the MCID imaging system (Imaging Research). β-actin was used as a 
loading control.  
 
RNA isolation and RT-PCR.  Total RNA was extracted from whole mouse brains and  
primary cortical neurons using Trizol isolation method (Invitrogen, Germany). RT-PCR was 
performed as described previously (Trollmann et al. 2008a, b). One µg of total RNA was used 
for each reverse transcription (MMLV reverse transcriptase, Invitrogen, Germany). RT cDNA 
products were measured by quantitative TaqMan RT-PCR. Commercial reagents (TaqMan 
PCR Reagent Kit, Perkin-Elmer Corp.) and conditions were applied according to the 
manufacturer´s protocol. The PCR reaction was performed in an ABI 7500 real-time PCR 
thermocycler (Applied Biosystems). All reactions were performed in duplicate using ß-actin 
and porphobilinogen deaminase (PBGD) as endogenous controls.   
The following primers and TaqMan probes based on published reports were used:  
ß-actin, forward: 5´- ATGCTCCCCGGGCTGTAT - 3´;  
reverse: 5´- TCACCCACATAGGAGTCCTTCTG - 3´;  
TaqMan probe: 5´(FAM) - ATCACACCCTGGTGCCTAGGGCG - (TAMRA) - 3´; 
ADM, forward: 5´- TGGACGAGCAGAACACAACTG - 3´; 
reverse: 5´ - CTGGCGGTAGCGTTTGACA - 3´; 
TaqMan probe: 5´(FAM) – CCCTACAAGCCAGCAATCAGAGCGAA - (TAMRA) - 3´; 
BNIP3, forward: 5´- ATTCCCCCCAAGGAGTTCCT – 3´; 
reverse: 5´- TTCATAACGCTTGTGTTTCTCATG – 3´; 
TaqMan probe: 5´(FAM) – ACACCCGAAGCGCACAGCTACTCTCA – (TAMRA) – 3´; 
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DUSP1, forward: 5´- TCCTAACCACTTTGAGGGTCACTAC - 3´; 
reverse: 5´ - CAGCATCCTTGATGGAGTCTATGA - 3´; 
TaqMan probe: 5´(FAM) – ACAAGAGCATCCCTGTGGAGGACAACC - (TAMRA) - 3´; 
EPO, forward: 5´- AAGGTCCCAGACTGAGTGAAAATATTAC - 3´; 
reverse: 5´ - GGACAGGCCTTGCCAAACT - 3´; 
TaqMan probe: 5´(FAM) – TCTATGGCCTGTTCTTCCACCTCCATTCT - (TAMRA) - 3´; 
IER3, Gene expression assay (Applied Biosystems; Germany; Mm00519290_g1)  
NGB, forward: 5´ - ATCGGGCAGTGGGAGTGA - 3´; 
reverse: 5´ - CAGGCACTTCTCCAGCATGTAG – 3´; 
TaqMan probe: 5´(FAM) – TCCTTCTCGACAGTAGGCGAGTCCCTG – (TAMRA) – 3´; 
PBGD, forward: 5´- ACAAGATTCTTGATACTGCACTCTCTAAG - 3´;  
reverse: 5´- CCTTCAGGGAGTGAACAACCA - 3´;  
TaqMan probe: 5´(FAM) - TCTAGCTCCTTGGTAAACAGGCTCTTCTCTCCA - 
(TAMRA)-3´;  
PHD2, forward: 5´- AAGCTGGGCAACTACAGGATAAA - 3´; 
reverse: 5´ - CGTGACGGACATAGCCTGTTC - 3´; 
TaqMan probe: 5´(FAM) – ACGAAAGCCATGGTTGCTTGTTACCCA - (TAMRA) - 3´; 
PHD3, forward: 5´- AGCCCATTTTTGACAGACTTCTG - 3´; 
reverse: 5´ - AGCGTACCTGGTGGCATAGG - 3´; 
TaqMan probe: 5´(FAM) – TCTGGTCAGACCGCAGGAATCCACAT - (TAMRA) - 3´; 
 
 
Fluorescence immunhistochemistry. For immunohistochemical analysis sections (3 µm) of 
paraformaldehyde-embedded brain tissues were used. After heat-induced epitope retrieval 
(Citrate buffer, pH 6, 10mM, S2369, DAKO, Germany), washing (PBS/Triton-X 0.1%) and 
blocking with Protein Block (X0909, Serum Free, DAKO, Germany) sections were incubated 
with the polyclonal rabbit anti-Ngb antibody (Santa Cruz Biotechnology, Santa Cruz, CA, 
1:100) over night at 4 °C. Negative controls were performed by omitting the primary 
antibody. After washing sections were incubated with Alexa Fluor 488-conjugated goat anti-
rabbit IgG (Invitrogen, Eugene, USA) secondary antibody for 60 min. After washing sections 
were co-stained with monoclonal mouse anti-GFAP (glial fibrillary acidic protein) antibody 
(1:50; Santa Cruz Biotechnology) to identify glial cells, or monoclonal mouse anti-NeuN 
(neuronal nuclei) antibody  (Chemicon Int. Hampshire, UK, 1:200), a routinely used neuronal 
marker, at room temperature for 2 h, followed by Alexa Fluor 594-conjugated goat anti-
mouse secondary antibody (Invitrogen, Eugene, USA). Cell nuclei were stained with DAPI 
(4′,6-diamidino-2-phenylindol). During all incubation periods sections were stored in a 
 10 
 
humidified chamber. Coverslips were mounted with Gel Mount Aqueous Mounting Medium 
(Sigma, St. Luis, USA) and air-dried.  
TUNEL staining. To determine degree of apoptosis-like cell death, terminal 
deoxynucleotidyl transferase-mediated dUTP end-labeling (TUNEL) staining (In Situ Cell 
Death Detection Kit, POD; Roche, Germany) of coronal sections at the level of dorsal 
hippocampus was performed 72 h and 7 d after systemic hypoxia (n=3 per group). The 
number of TUNEL-positive cells in parietal cortex and hippocampus (CA1) was then counted 
and compared to normoxic controls [3-6 fields/region per section were examined using the 
Olympus microscope BX51 (Tokyo, Japan)].  
Statistical analysis. Data are expressed as mean±SEM. Statistical significance was determined 
by One-way ANOVA and Two-way ANOVA for repeated measurements (p-value<0.05).  
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Results 
Cerebral Ngb expression is related to maturational stage. To evaluate maturational age-
related expression levels of Ngb during postnatal mouse brain development, we measured 
cerebral Ngb mRNA levels in normoxic brains of mice from 0 to 21 days of postnatal age and 
at P60. As demonstrated in Fig. 1, Ngb mRNA levels increased during the first postnatal 
weeks from P0 to P14 reaching peak levels at P14, and declined thereafter reaching levels 
comparable to those of adult brains (P60) at the end of third postnatal week. 
Immunohistochemical analysis revealed neuronal but not glial expression of Ngb throughout 
the developing cerebral cortex at P7 (Fig. 2). Of note, Ngb-positive neurons were found most 
prominently in cortical layers II/III.   
Cerebral Ngb expression is related to the degree of hypoxia. To investigate effects of 
hypoxia on cerebral Ngb expression during early postnatal brain development, we analyzed 
Ngb mRNA and protein expression in brains of neonatal mice at the age of P0 and P7 exposed 
to acute or chronic hypoxia. Whereas acute systemic hypoxia (8% O2) for 6 hours did not 
markedly alter cerebral Ngb mRNA levels at P7, there was a significant up-regulation of Ngb 
mRNA concentrations at P0 compared to controls (Fig. 3A). However, hypoxia-induced Ngb 
up-regulation did not persist during reoxygenation (21% O2 for 24 h, 72 h, and 7 d) following 
exposure to acute hypoxia (Fig. 3B). The increase of cerebral Ngb mRNA concentrations with 
postnatal age in normoxic brains (Fig. 3B) reflects an age-related phenomenon as shown in 
Fig. 1.  Interestingly, this age-specific up-regulation of Ngb appeared to be transiently 
suppressed upon acute hypoxia (Fig. 3B) as suggested by unchanged mean Ngb mRNA levels 
during the first 72 h of reoxygenation in contrast to normoxic controls.    
To confirm the severity of acute hypoxia used in our experimental setting, several hypoxia-
inducible genes as well as markers of apoptosis were analyzed (Fig. 4 A-G). At both 
maturational stages P0 and P7, mRNA expression of HIF-regulated vasoactive and 
neurotrophic factors (ADM, EPO) and pro-apoptotic genes (BNIP3, IER3) was significantly 
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increased compared to normoxic controls with no apparent age-related differences. Similarly, 
cerebral mRNA concentrations of the HIF-dependent PHD2 and PHD3 isoforms (Fig 4E, F) 
were up-regulated during acute hypoxia compared to normoxic controls in both P0 and P7 
brains. In contrast, mRNA levels of the proapoptotic HIF target gene DUSP1 were 
significantly elevated in hypoxic developing brain at P0 compared to controls but not at P7 
(Fig. 4G) indicating age-related differential regulation of DUSP1 by hypoxia. Functional 
activation of cerebral apoptosis following acute systemic hypoxia (8% O2, 6h) was confirmed 
by TUNEL staining of forebrain sections upon reoxygenation periods of 24 h, 72 h and 7 d 
(Fig. 5) which demonstrated increased numbers of TUNEL+ cells in parietal cortex (Fig. 5 B, 
H) and hippocampus (Fig. 5 D).    
Since acute hypoxia was found to be a stimulus for Ngb induction during early brain 
development, cellular and spatial distribution of Ngb in hypoxic developing brains was 
determined by immunohistochemistry (Fig. 6). A hypoxia-induced increase in Ngb at P0 was 
confirmed at the protein level by demonstrating a markedly higher number of Ngb-positive 
cells in the parietal cortex of hypoxic compared to normoxic mouse brains (Fig. 6 A vs B). 
This was in contrast to hypoxic mouse brains at P7, in which there was an unchanged number 
and distribution pattern of Ngb-positive cells compared to controls (Fig. 6 C vs D). Notably, 
co-staining with NeuN and GFAP demonstrated cytoplasmic accumulation of Ngb in hypoxic 
neurons (Fig. 2C, D) but not glia cells (Fig. 2B) throughout the developing cerebral cortex.  
To determine whether Ngb expression is also modulated by chronic hypoxia during early 
stages of brain maturation, analyses were extended to brains exposed to systemic chronic 
hypoxia at P7 (10% O2 for 7 d). As demonstrated in Table 1, cerebral Ngb mRNA levels did 
not significantly differ between chronic hypoxic and normoxic tissues either at the end of 
hypoxic exposure or during reoxygenation periods. To compare Ngb mRNA levels to other 
HIF-regulated genes, we determined mRNA concentrations of BNIP3, ADM, EPO, PHD2 
and PHD3, DUSP1 and IER3. In contrast to our observations during acute hypoxia, there 
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were no significant differences in selected HIF target gene expression between normoxic and 
hypoxic brain except for a significant EPO up-regulation, and, of note, a more than 2-fold 
increase of BNIP3 mRNA levels following a 24 hr reoxygenation period in comparison to 
normoxic controls (Table 1). 
Hypoxic induction of cerebral Ngb expression is mediated by HIF. To examine whether 
hypoxia-induced up-regulation of Ngb expression is mediated by HIF stabilization and 
activation during acute hypoxia, two approaches were taken. First, by in vitro experiments 
with mouse embryonic neuronal cultures (E14, DIV6) we compared induction of Ngb mRNA 
levels between neurons exposed to hypoxia (1% O2, 6h) and in neurons pre-treated with FG-
4497 (0.1-1 µM) before incubation under either normoxic or hypoxic conditions. Hypoxia 
induced a more than three-fold increase in Ngb mRNA levels compared to controls (Fig. 7A). 
Similar transcriptional activation of Ngb was found in response to FG-4497 under normoxia 
(Fig. 7A) indicating HIF-dependent regulation of Ngb at the mRNA level. Notably, Ngb 
mRNA levels did not significantly vary between cells grown in hypoxic and hypoxic+FG-
4497 conditions, suggesting no additive effects of hypoxia and PHI treatment. In addition, 
FG-4497-induced HIF-1α stabilization in these neuronal cultures was verified by western blot 
analysis (Fig. 7B), revealing prominent HIF-1α protein accumulation under normoxia at 
concentrations of 30-60 µM. Once again, there were no additive effects of hypoxic+FG-4497 
conditions compared with hypoxic controls (Fig. 7B). Conversely, additive effects of hypoxia 
and FG-4497 are observed for the HIF-dependent gene, ADM (Fig. 7D). BNIP3 mRNA levels 
on the other hand, increased in response to hypoxia and FG-4497 without comparable additive 
effects (Fig. 7C).   
The second approach taken was to analyze cerebral Ngb expression in vivo in response to PHI 
treatment (30, 60 and 100 mg/kg, i.p.) under normoxic conditions (Table 2). No significant 
difference in mean Ngb mRNA expression level was detected between vehicle-treated and 
FG-4497-treated neonatal mouse brains at both maturational stages P0 and P7. In addition, 
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FG-4497 treatment did not significantly alter mRNA levels of the HIF-regulated BNIP3 in 
neonatnal mouse brain at either P0 or P7.   
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Discussion 
A wide spectrum of endogenous hypoxia-inducible mediators are involved in critical 
mechanisms of early brain maturation (Fandrey et al., 2006) as well as compensation  during 
hypoxic and ischemic injury of the developing brain (Curristin et al., 2002). Here, we show 
that Ngb expression develops age-dependently with increasing Ngb levels during early 
postnatal mouse brain maturation (P0-P14), and that Ngb is localized mainly in the cytoplasm 
of neurons at this early stage of brain development. Further, using a neonatal mouse model of 
systemic hypoxia we demonstrate that Ngb response to hypoxia varies with maturational stage 
and degree of hypoxia. Another major finding of the present study is that hypoxia-induced 
Ngb up-regulation is HIF-dependent as shown in vitro by pharmacological HIF stabilization.  
 
Cerebral Ngb expression is related to maturational stage. Focusing on physiological 
expression of Ngb during mouse brain development, we report for the first time a 
developmental transient increase of Ngb expression at the end of the 2nd postnatal week. 
Thus, present data extend previous findings on age-specific regulation of Ngb expression 
which demonstrated an age-related decline in 3 to 12-month-old rodents (Sun et al., 2005). 
Previous studies on adult mouse brain have suggested multi-regional expression of Ngb 
(Wystub et al., 2003), whereas others have not been able to detect either Ngb-positive neurons 
(Mammen et al., 2002) or glia cells (Hundahl et al., 2005) in the normoxic adult mouse 
cerebral cortex and hippocampus. Although spatial expression and functional role of Ngb 
during early development are not yet well defined, increasing levels of  Ngb mRNA from P0 
to P14 in developing mouse forebrain as shown here may indicate an important role of Ngb in 
the regulation of crucial processes of early postnatal mouse brain development. Indeed, 
neurons of the developing mouse cerebral cortex representing a metabolically active region 
during early brain maturation were found to highly express Ngb under normoxic conditions. 
The ability of Ngb to modify O2 homeostasis by mitochondrial pathways (Raychaudhuri et al., 
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2009) might improve early cell survival, neurogenesis and, finally, brain plasticity. In 
accordance with others (Sun et al., 2003, Hundahl et al., 2005) we did not observe co-
expression of Ngb with GFAP suggesting that Ngb does not play a major role in early 
postnatal glial development.  
 
Cerebral Ngb expression follows the degree of systemic hypoxia and stage of maturation. The 
severity of acute brain hypoxia (8% O2, 6h) induced in our experimental setting is supported 
by significant induction of apoptosis in vulnerable brain regions shown by TUNEL staining. 
In addition, transcriptional up-regulation of pro-apoptotic genes, namely BNIP3 (Zhang et al., 
2007), IER3 and DUSP1, indicates activation of cerebral pro-apoptotic mechanisms by early 
postnatal exposure to acute hypoxia (8% O2, 6h). Additionally, the consistent increase of HIF-
regulated vasoactive genes (ADM), neurotrophic genes (EPO) and PHDs in response to acute 
hypoxia compared to normoxia indicates activation of the HIF-system due to cerebral oxygen 
deprivation at P0 and P7. Of note, we have previously shown HIF-1α and HIF-2α activation 
in postnatal mouse brain at P0 and P7 in response to acute systemic hypoxia (8% O2, 6h) 
(Trollmann et al., 2008a).  
At early stage of mouse brain maturation (P0), acute but not chronic hypoxia increased 
cerebral Ngb expression as demonstrated by increased mRNA levels in forebrain 
homogenates and higher numbers of Ngb-positive neurons throughout hypoxic developing 
cerebral cortex compared to normoxic controls. Of note, the rapid decline of Ngb mRNA 
levels observed during reoxygenation indicates a transient up-regulation of Ngb during the 
early response to acute hypoxia - this was found exclusively during early development (P0) 
but not at P7. In contrast, studies on adult mice showed no detectable difference in cerebral 
Ngb expression between normoxic and hypoxic brains either at the protein or mRNA levels 
upon short-term hypoxia (7.6% O2, 2h) (Hundahl et al., 2005). In accordance with PCR and 
ISH studies on adult mouse brain under chronic hypoxic conditions (10% O2; up to two 
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weeks) (Mammen et al., 2002) we did not detect any differences in Ngb expression between 
chronically hypoxic brains and normoxic controls either at P0 or at P7, even with 
reoxygenation periods up to 7d (data not shown). Thus, present results suggest that Ngb 
transcriptional regulation is affected by acute but not by chronic hypoxia, and interestingly, 
that acute hypoxic induction of cerebral Ngb represents an age-dependent, transient 
phenomenon during early brain development.   
 
Hypoxic induction of cerebral Ngb expression is mediated by HIF. PHI treatment allows the 
analysis of HIF stabilization as well as HIF target gene activation under normoxic conditions 
(Paliege et al., 2010, Robinson et al., 2008, Rosenberger et al., 2008). Recent studies from our 
group have shown that a novel PHI, FG-4497, can penetrate the blood-brain-barrier and 
activate vasoactive and neurotrophic HIF target genes in a dose-dependent manner in 
developing mouse brain at P7 (Schneider et al., 2009). Expanding on these previous 
observations, in the current study we demonstrate an increase in Ngb transcription in neuronal 
cells in response to FG-4497 treatment. This in vitro data suggests that the hypoxic regulation 
of Ngb mRNA expression is HIF-dependent. However, FG-4497-induced regulation of Ngb 
expression could not be confirmed in vivo in developing mouse brain at P0 and P7. As 
developmentally different regulation has to be considered, further in vivo investigations at 
different maturational stages are necessary. Additionally, differential regulation and 
sensitivity of HIF target genes in vivo (Trollmann et al., 2008a) might be another possible 
explanation of contradictory in vitro and in vivo observations.  
Although there are conflicting hypotheses about the potential effects of PHI treatment in 
neonatal brain (Chen et al., 2009), pharmacologic inhibition of PHD hydroxylation leading to 
HIF accumulation has been proposed as a possible target for neuroprotection (Siddiq et al., 
2005, Adamcio et al., 2009)). In vitro, HIF stabilization by FG-4497 has been shown to 
enhance proliferation, neurogenesis and differentiation of human neural progenitor cells 
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(Milosevic et al., 2009). In contrast, depending on the degree of hypoxia and the cell type 
induction of pro-apoptotic mechanisms has been linked to overexpression of HIF (Helton et 
al., 2005, Chen et al., 2009). This is of special significance in the developing brain as since 
disturbance of physiological apoptosis which plays a crucial role in early brain development 
(Sandau and Handa, 2006), might be detrimental. In accordance to reported evidence that 
HIF-1 induces BNIP3 expression (Guo et al., 2001), we have shown a significant up-
regulation of cerebral BNIP3 mRNA levels in response to FG-4497 in vitro under normoxic 
conditions. Notably, this was not confirmed in vivo.  BNIP3 is known as a central mediator of 
hypoxia-induced autophagy that could result in adaptive survival as well as cell death 
depending on the degree of hypoxia (Tracy et al., 2007, Bellot et al., 2009). In contrast to 
severe hypoxic conditions or anoxia (<0.1% O2) which trigger HIF-independent autophagic 
response, sublethal hypoxia (as used in our model) induces mitochondria-associated proteins 
BNIP3 and BNIP3L (NIX) which have been suggested to mediate a metabolic adaptation for 
survival by their ability to control reactive oxygen species production and DNA damage 
(Bellot et al., 2009). Of interest, Aminova et al. (2008) showed that antioxidants and PHD 
inhibitors prevent HIF-mediated transactivation of BH3-only proteins minimizing pro-death 
effects of HIF-1α overexpression on neurons exposed to oxidative stress. We intend to 
address functional significance of early Ngb versus BNIP3 induction by pharmacological HIF 
overexpression in the hypoxic developing mouse brain in future studies.  
In conclusion, our in vivo results demonstrate for the first time that Ngb expression increases 
age-dependently in the developing mouse brain and that Ngb expression in response to 
hypoxia varies with maturational stage as well as the degree of hypoxia, indicating a role in 
neuronal adaptation to acute hypoxia during early stage of mouse brain maturation (P0). 
Regarding hypoxic regulation of Ngb, our in vitro results suggest involvement of HIF-
dependent mechanisms.  Taken together, our data provide basic information for further 
 19 
 
investigations on pathophysiology of postnatal cerebral hypoxic response in view of novel 
and maturational-age specific neuroprotective concepts.  
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Legends to Figures and Tables 
 
Fig. 1 Ngb mRNA expression  normalized to β-actin  in mouse brain in relation to 
maturational age  P0-P60 . N=4 per group, **p<0.01  
 
Fig. 2 Immunohistochemical analysis of Ngb in normoxic mouse cerebral cortex at P7. 
Merged photomicrographs of Ngb  detected with Alexa Fluor 488, green  and GFAP  detected 
with Alexa Fluor 594, red  are shown in A and B, and of Ngb and NeuN  detected with Alexa 
Fluor 594, red  in C and D. A Overview of parietal cortex. Co-staining of Ngb with GFAP 
demonstrating Ngb+ cells most prominently in cortical layers II and III. B Higher 
magnification did not reveal Ngb expression in GFAP+ glial cells. C, D Co-staining of Ngb 
with NeuN showing localisation of Ngb in neurons.  
 
Fig. 3 A Maturational stage-dependent up-regulation of Ngb mRNA levels  normalized to 
PBGD  in developing mouse brain  P0, P7  in response to acute hypoxia  8% O2; 6h  
compared to normoxic controls, N=5 per group. B Transient down-regulation of Ngb mRNA 
levels in hypoxic developing mouse brains at P0 during reoxygenation  R  compared to 
normoxic brains. R, reoxygenation intervals of 24h, 72h and 7d. N=3 per group. **p<0.01 
 
Fig. 4 Up-regulation of cerebral mRNA levels of HIF-dependent target genes in response to 
acute systemic hypoxia at P0 and P7 compared to normoxia. Independently from maturational 
stage mRNA concentrations of BNIP3  A , ADM  B , IER3  F , EPO  G  and PHD isoforms  
C, D  significantly increased during acute hypoxia compared to normoxia. E Differential 
regulation of DUSP1 mRNA expression in relation to maturational stage in response to acute 
hypoxia compared to controls. N=5 per group, *p<0.05; **p<0.01    
 
Fig. 5 Degree of hypoxia  8% O2,6h -induced apoptotic cell death  TUNEL staining  in 
parietal cortex  B   and hippocampus  C  of 7-day old mice upon reoxygenation period of 72 h 
compared to normoxic controls  D, E . Quantification of TUNEL+ cells in the parietal cortex  
F  upon reoxygenation  R  of 24 h, 72 h and 7 d  N=3 per group  compared to controls. Scale 
bars in B-E: 100 µm; * p<0.05, ** p<0.01 
 
Fig. 6 Immunohistochemical analysis of Ngb in mouse cerebral cortex at P0  A  and P7  C  
under normoxic and hypoxic  8% O2, 6h; B, D  conditions. Merged photomicrographs of Ngb  
detected with Alexa Fluor 488, green  and NeuN  detected with Alexa Fluor 594, red  are 
shown. Nuclei are counterstained with DAPI  blue .  An increased number of Ngb+ cells was 
detectable during acute hypoxia  B  compared to normoxia  A  at P0. In contrast, this hypoxia-
induced increase was not found in cortices of 7-day-old mice  D  in comparison to controls  C 
.   
  
Fig. 7 Effects of PHI FG-4497 on Ngb and HIF activation in embryonic mouse neurons  E14, 
DIV6  under normoxic and hypoxic  1% O2  conditions. A Up-regulation of Ngb mRNA 
levels  normalized to β-actin  in normoxic FG-4497-treated and hypoxic non-treated neurons 
compared to controls without additive effects in FG-4497-treated hypoxic cells. B  Western 
blot analysis and densitometric quantification of HIF-1α protein in neurons exposed to 
indicated concentrations of FG-4497 under normoxic and hypoxic conditions. 2,2´-dipyridyl 
was used as a positive control. C, D Up-regulation of BNIP3 and ADM mRNA levels in 
normoxic FG-4497-treated neurons and in non-treated hypoxic neurons compared to controls.  
**p<0.01; ***p<0.001  
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Table 1. Gene expression of HIF-dependent and HIF-independent factors in developing 
mouse brain exposed to chronic hypoxia and chronic hypoxia followed by a 24h 
reoxygenation interval  R24h  in comparison to controls  mean ± SEM . 
mRNA levels 
normalized to 
β-actin   normoxia 
chronic 
hypoxia 
 
normoxia 
 + R24h   
 
chronic 
hypoxia  
 + R24h  
 n=5 n=3 n=5 n=3 
Ngb 1.80±0.22 2.01±0.05 0.40±0.18 0.82±0.35 
BNIP3 1.24±0.07 1.40±0.08   0.53±0.07*    1.24±0.19* 
ADM 0.73±0.03 0.81±0.04 0.38±0.08 0.57±0.07 
EPO 0.06±0.01     0.74±0.09** 0.01±0.00     0.08±0.04** 
PHD2 0.78±0.23 1.14±0.05 0.16±0.05 0.32±0.13 
PHD3 0.73±0.03 0.81±0.04 0.43±0.05 0.57±0.07 
DUSP1 1.61±0.32 1.46±0.12 0.37±0.07 0.43±0.25 
IER3 0.86±0.12 1.01±0.11 0.65±0.05 0.70±0.08 
     
* p < 0.05; ** p < 0.01 
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Table 2. Gene expression of Ngb, BNIP3 and ADM in developing mouse brain at P0 and P7  
n=4  upon FG-4497 treatment  30-100 mg/kg; i.p.; 6h  in comparison to controls  mean ± 
SEM . 
 
mRNA levels 
normalized to 
β-actin 
Ngb BNIP3 ADM 
 
P0 
 
P7 
 
P0 
 
P7 
 
P0 
 
P7 
non treated 0.18±0.07 0.41±0.08 0.20±0.04 0.52±0.17 0.06±0.01 0.05±0.01**
NaCl 0.9 % 0.37±0.03 0.65±0.07 0.18±0.03 0.58±0.04 0.03±0.01** 0.06±0.01 
PHI, 30 mg/kg  0.30±0.06 0.48±0.06 0.28±0.06 0.62±0.08 0.11±0.01** 0.14±0.03 
PHI, 60 mg/kg 0.28±0.05 0.35±0.25 0.25±0.01 0.77±0.36 0.09±0.01 0.11±0.02 
PHI, 100 mg/kg 0.42±0.15 0.21±0.09 0.22±0.03 0.53±0.12 0.09±0.01 0.29±0.04**
** p < 0.01 vs controls  
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